Search research articles
Contact Us
Filters
Showing results (101-110 of 621) with videos related to
Page
of 63
Sort By:
Surgical Oncology Clinics of North America
|
November 22, 2011
Preoperative and postoperative chemotherapy for gastric cancer
Vikram K Jain, David Cunningham, Ian Chau
Oncotargets and Therapy
|
August 16, 2016
Clinical role of ramucirumab alone or in combination with paclitaxel for gastric and gastro-esophageal junction adenocarcinoma
Michael Davidson, Elizabeth C Smyth, David Cunningham
Emergency Medicine Journal : EMJ
|
February 26, 2026
Use of nasal high-flow in emergency departments: a four-nation UK-wide survey
Cal Doherty, David Cunningham, Fiona Marie Burton
Leukemia & Lymphoma
|
May 24, 2012
Diagnosis and management of rare gastrointestinal lymphomas
Eliza A Hawkes, Andrew Wotherspoon, David Cunningham
JAMA Oncology
|
February 13, 2016
AREG and EREG as Predictive Biomarkers for RAS Wild-Type Colorectal Cancer Treated With Panitumumab: A Fresh Approach to an Old Puzzle
Elizabeth C Smyth, Khurum Khan, David Cunningham
European Journal of Cancer (Oxford, England : 1990)
|
June 28, 2005
The frequency and pattern of cardiotoxicity observed with capecitabine used in conjunction with oxaliplatin in patients treated for advanced colorectal cancer (CRC)
Matthew Ng, David Cunningham, Andrew R Norman
Current Treatment Options in Oncology
|
April 2, 2016
Esophagogastric Adenocarcinoma: Is More Chemotherapy Better?
Elisa Fontana, Elizabeth C Smyth, David Cunningham
American Journal of Surgery
|
March 25, 2009
Surgical outcomes following pancreatic resection at a low-volume community hospital: do all patients need to be sent to a regional cancer center?
John David Cunningham, Nancy O'Donnell, Paul Starker
Immunotherapy
|
December 20, 2014
Potential role of rilotumumab in the treatment of gastric cancer
Tom Waddell, Sing Yu Moorcraft, David Cunningham
Oncotargets and Therapy
|
June 25, 2014
Emerging molecular targets in oncology: clinical potential of MET/hepatocyte growth-factor inhibitors
Elizabeth C Smyth, Francesco Sclafani, David Cunningham
Page
of 63
Search research articles
Search
Showing results (101-110 of 621) with videos related to
Sort By:
Page
of 63
Surgical Oncology Clinics of North America
|
November 22, 2011
Preoperative and postoperative chemotherapy for gastric cancer
Vikram K Jain, David Cunningham, Ian Chau
Oncotargets and Therapy
|
August 16, 2016
Clinical role of ramucirumab alone or in combination with paclitaxel for gastric and gastro-esophageal junction adenocarcinoma
Michael Davidson, Elizabeth C Smyth, David Cunningham
Emergency Medicine Journal : EMJ
|
February 26, 2026
Use of nasal high-flow in emergency departments: a four-nation UK-wide survey
Cal Doherty, David Cunningham, Fiona Marie Burton
Leukemia & Lymphoma
|
May 24, 2012
Diagnosis and management of rare gastrointestinal lymphomas
Eliza A Hawkes, Andrew Wotherspoon, David Cunningham
JAMA Oncology
|
February 13, 2016
AREG and EREG as Predictive Biomarkers for RAS Wild-Type Colorectal Cancer Treated With Panitumumab: A Fresh Approach to an Old Puzzle
Elizabeth C Smyth, Khurum Khan, David Cunningham
European Journal of Cancer (Oxford, England : 1990)
|
June 28, 2005
The frequency and pattern of cardiotoxicity observed with capecitabine used in conjunction with oxaliplatin in patients treated for advanced colorectal cancer (CRC)
Matthew Ng, David Cunningham, Andrew R Norman
Current Treatment Options in Oncology
|
April 2, 2016
Esophagogastric Adenocarcinoma: Is More Chemotherapy Better?
Elisa Fontana, Elizabeth C Smyth, David Cunningham
American Journal of Surgery
|
March 25, 2009
Surgical outcomes following pancreatic resection at a low-volume community hospital: do all patients need to be sent to a regional cancer center?
John David Cunningham, Nancy O'Donnell, Paul Starker
Immunotherapy
|
December 20, 2014
Potential role of rilotumumab in the treatment of gastric cancer
Tom Waddell, Sing Yu Moorcraft, David Cunningham
Oncotargets and Therapy
|
June 25, 2014
Emerging molecular targets in oncology: clinical potential of MET/hepatocyte growth-factor inhibitors
Elizabeth C Smyth, Francesco Sclafani, David Cunningham
Page
of 63